Clinical Trials in Wuzhou, Guangxi
11 recruiting
Showing 1–11 of 11 trials
Recruiting
Phase 3
Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy
Nasopharyngeal Carcinoma (NPC)
Ming-Yuan Chen456 enrolled12 locationsNCT07328841
Recruiting
Phase 3
40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
Ming-Yuan Chen346 enrolled15 locationsNCT07328854
Recruiting
Not Applicable
Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy
Locally Advanced Nasopharyngeal Carcinoma
First Affiliated Hospital of Guangxi Medical University190 enrolled20 locationsNCT05892354
Recruiting
Diagnostic Accuracy of EBV C Promoter Methylation Kit in Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
Sun Yat-sen University908 enrolled5 locationsNCT06445088
Recruiting
Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City
Nasopharyngeal Carcinoma
Zhongshan People's Hospital, Guangdong, China40,000 enrolled2 locationsNCT04085900
Recruiting
Phase 3
Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
Wei Jiang440 enrolled2 locationsNCT05527470
Recruiting
Phase 2
Camrelizumab for the Treatment of Locally Advanced Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
Wei Jiang200 enrolled5 locationsNCT05097209
Recruiting
Not Applicable
Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma by AJCC V8 Stage
Fourth Affiliated Hospital of Guangxi Medical University288 enrolled9 locationsNCT05717790
Recruiting
Phase 3
Toripalimab Plus Concurrent Chemo-radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma
ChemotherapyRadiotherapyNasopharyngeal Carcinoma+1 more
Sun Yat-sen University226 enrolled6 locationsNCT04453813
Recruiting
Phase 3
Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma
ChemotherapyRadiotherapyNasopharyngeal Cancer+1 more
Sun Yat-sen University388 enrolled6 locationsNCT04453826
Recruiting
Phase 3
Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma
ChemotherapyRadiotherapyNasopharyngeal Carcinoma
Sun Yat-sen University508 enrolled6 locationsNCT04448522